Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

3.860

+0.020 (0.52%)

At close: May 29, 2026, 4:00 PM EDT

3.970

+0.110 (2.85%)

After-hours: May 29, 2026, 6:45 PM EDT

Niagen Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	130.42	129.42	99.6	83.57	72.05	67.45
Revenue Growth (YoY)	20.84%	29.95%	19.18%	15.99%	6.82%	13.83%
Cost of Revenue	46.58	46.23	38.01	32.79	29.25	25.96
Gross Profit	83.83	83.19	61.59	50.78	42.8	41.49
Selling, General & Admin	66.18	62.56	47.84	51.42	56.6	64.73
Research & Development	6.55	6.33	6.02	4.96	4.83	3.83
Other Operating Expenses	1.98	1.98	-	-	-	-
Total Operating Expenses	74.72	70.88	53.86	56.38	61.43	68.56
Operating Income	9.12	12.31	7.73	-5.6	-18.63	-27.07
Interest Income	-	-	-	-	2.09	-
Other Non-Operating Income (Expense)	6.95	3.83	2.26	0.66	0	-0.06
Total Non-Operating Income (Expense)	6.95	3.83	2.26	0.66	2.09	-0.06
Pretax Income	16.07	16.14	9.98	-4.94	-16.54	-27.13
Provision for Income Taxes	1.06	0.81	0.31	0	-	-
Net Income	18.64	17.38	8.55	-4.94	-16.54	-27.13
Net Income to Common	18.64	17.38	8.55	-4.94	-16.54	-27.13
Net Income Growth	32.13%	103.30%	-	-	-	-
Shares Outstanding (Basic)	79	79	76	75	70	67
Shares Outstanding (Diluted)	85	85	78	75	70	67
Shares Change (YoY)	7.42%	9.36%	4.19%	7.54%	3.79%	10.02%
EPS (Basic)	0.24	0.22	0.11	-0.07	-0.24	-0.40
EPS (Diluted)	0.21	0.20	0.11	-0.07	-0.24	-0.40
EPS Growth	18.45%	81.82%	-	-	-	-
Shares Outstanding	79.46	79.71	77.33	74.98	74.57	68.13
Free Cash Flow	4.11	13.21	11.95	6.97	-15.43	-24.57
Free Cash Flow Growth	-68.92%	10.60%	71.42%	-	-	-
Free Cash Flow Per Share	0.05	0.15	0.15	0.09	-0.22	-0.37
Gross Margin	64.28%	64.28%	61.84%	60.76%	59.40%	61.51%
Operating Margin	6.99%	9.51%	7.76%	-6.70%	-25.85%	-40.14%
Profit Margin	11.51%	11.84%	9.72%	-5.91%	-22.96%	-40.22%
FCF Margin	3.15%	10.21%	11.99%	8.34%	-21.42%	-36.43%
EBITDA	10	13.1	8.54	-4.57	-17.57	-25.96
EBITDA Margin	7.67%	10.12%	8.57%	-5.47%	-24.39%	-38.49%
EBIT	9.12	12.31	7.73	-5.6	-18.63	-27.07
EBIT Margin	6.99%	9.51%	7.76%	-6.70%	-25.85%	-40.14%
Effective Tax Rate	6.59%	5.02%	3.05%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q